Stay updated on Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.

Latest updates to the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedA new revision tag was added: v3.5.4, replacing v3.5.3. This reflects an updated release/version of the page's underlying documentation or template.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer now shows an updated site revision number (v3.5.3) instead of the previous one (v3.5.2), indicating a change in the page build/version rather than study details.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be an internal version control update with no substantive changes to the study details.SummaryDifference0.0%

- Check65 days agoChange Detected- Revision: added v3.5.0; removed v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check100 days agoChange DetectedRevision: v3.4.2 was added to the page. The government funding lapse notice and Revision: v3.4.1 notice were removed.SummaryDifference0.3%

Stay in the know with updates to Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in COVID-19: Efficacy & Safety Clinical Trial page.